Theravance Biopharma, Inc. - Common Stock (TBPH)

145 filings reported holding TBPH - Theravance Biopharma, Inc. - Common Stock as of Q2 2024.
Theravance Biopharma, Inc. - Common Stock (TBPH) has 129 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 47.1M shares of 49.8M outstanding shares and own 94.64% of the company stock.
Largest 10 shareholders include Madison Avenue Partners, LP (8.51M shares), Weiss Asset Management LP (7.46M shares), BAUPOST GROUP LLC/MA (4.2M shares), BlackRock Inc. (3.78M shares), Irenic Capital Management LP (2.76M shares), Newtyn Management, LLC (2.12M shares), VANGUARD GROUP INC (2M shares), Park West Asset Management LLC (1.7M shares), STATE STREET CORP (1.27M shares), and Oasis Management Co Ltd. (1.16M shares).
This table shows the top 129 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.